IL1B and inflammatory bowel disease: This contradiction may reflect a role for NLRP7 in preventing inflammasome formation and IL-1β release in quiescent cells while activating the inflammasome in response to bacterial infection.25 In either case, this would be consistent with the association of NLRP7 mutations with immune-mediated disorders such as IBD.